17-alpha-hydroxyprogesterone has been researched along with Absence Status in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bidlingmaier, F; Dörr, HG; Holthausen, H; Knorr, D; Kuhnle, U | 1 |
1 other study(ies) available for 17-alpha-hydroxyprogesterone and Absence Status
Article | Year |
---|---|
Etomidate: a selective adrenocortical 11 beta-hydroxylase inhibitor.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Child; Corticosterone; Cortisone; Cortodoxone; Desoxycorticosterone; Etomidate; Humans; Hydrocortisone; Hydroxyprogesterones; Imidazoles; Male; Progesterone; Status Epilepticus; Steroid 11-beta-Hydroxylase; Steroid Hydroxylases | 1984 |